Delivery Order SPE2DR25D7068-SPE2DR26F5BY5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units, with a ceiling value of $31,115.81. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $23,424.76 to AmerisourceBergen Drug Corp for Adderall 20 mg tablets (100 count) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 20 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $2,451.32. This non-set-aside award was issued on December 3, 2025, with an ultimate completion date of December 4, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a primary distribution hub for federal pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order on August 5, 2025, by the Defense Logistics Agency to supply 100 tablets of Adderall 20 mg. The contract is a firm fixed-price delivery order with a ceiling value of $10,740.13 and an ultimate completion date of August 6, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.86 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units) with a completion deadline of June 2, 2025. This is a competitively awarded, firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed-price contract valued at $4,431.07, with an ultimate completion date of October 31, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,838.49 to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100 count) with a completion date of December 1, 2025. This competitive award, made on November 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $3,676.98 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count) on December 10, 2025, with completion scheduled for December 11, 2025. This competitively awarded, firm fixed-price delivery order utilizes a non-set-aside procurement vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $50,741.24. The contract was competitively awarded without a set-aside designation and is scheduled for completion by September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BY5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 20 mg tablets (100s) with a ceiling value of $9,254.51 under a firm fixed price contract type. The award was made on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a non-competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supplying pharmaceuticals across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 12/14/25 |